Metastatic insulinoma presenting 14 years after benign tumour resection: a rare case and management dilemma
Endocrinology, Diabetes & Metabolism Case Reports · 23.09.2020 · 2020
DOI: 10.1530/edm-20-0065 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology, Diabetes & Metabolism Case Reports, erschienen am 23.09.2020. Verfasst von F Keen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes and Endocrinology, Royal Glamorgan Hospital, Llantrisant, UK. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
We present a 60-year-old woman who underwent successful surgical resection (partial pancreatectomy) for a low grade non-functioning pancreatic neuroendocrine tumour (pNET), with no biochemical or radiological features of recurrence on follow-up visits for 5 years. Fourteen years after the initial surgery, she developed spontaneous severe hypoglycaemic episodes which required hospitalisation, with subsequent investigations confirming the diagnosis of a metastatic insulin-secreting pNET (insulinoma). Medical management of her severe spontaneous hypoglycaemic episodes remained challenging, despite optimum use of diazoxide and somatostatin analogue therapy. Based on a discussion at the regional neuroendocrine tumour multidisciplinary team meeting, she underwent an elective hepatic trans-arterial embolization which was unfortunately unsuccessful. She ended up requiring an emergency right hemihepatectomy and left retroperitoneal mass resection which finally stabilised her clinical condition. Learning points: Ours is only the seventh case report of a previously benign pNET presenting as a functional insulin secreting metastatic tumour. However, it is the first case report, in which the metastatic functional pNET presented after such a long hiatus (14 years). There is currently no clear consensus regarding the length of follow-up of non-functional pNET which are deemed cured post-surgical resection, with most guidelines advocating a median follow up of 5 years (1). The delayed presentation in our case suggests additional considerations should be made regarding optimal post-operative surveillance duration based on the age of the patient, location of the tumour, lymph node spread and Ki-67 index. Hepatic artery embolization and/or partial hepatectomy remains a treatment option for pNET patients with significant hepatic metastasis.
Autor:innen und Institutionen
- Department of Diabetes and Endocrinology, Royal Glamorgan Hospital, Llantrisant, UK.
- Morriston Hospital, Swansea, UK.
- University Hospital of Wales, Cardiff, UK.
Zitieren
APA
Keen, F., Iqbal, F., Owen, P., Christian, A., Kumar, N., & Kalhan, A. (2020). Metastatic insulinoma presenting 14 years after benign tumour resection: a rare case and management dilemma. Endocrinology, Diabetes & Metabolism Case Reports, 2020. https://doi.org/10.1530/edm-20-0065
Vancouver
Keen F, Iqbal F, Owen P, Christian A, Kumar N, Kalhan A. Metastatic insulinoma presenting 14 years after benign tumour resection: a rare case and management dilemma. Endocrinology, Diabetes & Metabolism Case Reports. 2020;2020. doi:10.1530/edm-20-0065
BibTeX
@article{Keen2020,
author = {Keen, F and Iqbal, F and Owen, P and Christian, A and Kumar, N and Kalhan, A},
title = {Metastatic insulinoma presenting 14 years after benign tumour resection: a rare case and management dilemma},
journal = {Endocrinology, Diabetes & Metabolism Case Reports},
year = {2020},
volume = {2020},
doi = {10.1530/edm-20-0065}
}
EUVIMED